Arteriovenous Fistula Devices Market Size, Share, Opportunities, And Trends By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-Use (Hospitals, Ambulatory Surgical Centers, Dialysis Centers), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2025 To 2030
Comprehensive analysis of demand drivers, supply-side constraints, competitive landscape, and growth opportunities across applications and regions.
Description
Arteriovenous Fistula Devices Market Size:
The arteriovenous fistula devices market is estimated to attain a market size of USD 1,367.103 million by 2030, growing at a 6.49% CAGR from a valuation of USD 998.507 million in 2025.
AVF devices are chosen over alternatives such as catheters or arteriovenous grafts for vascular access because of their longevity, decreased risk of infection, and better long-term results. These tools are essential for helping ESRD patients obtain vascular access and allowing successful hemodialysis treatments. For instance, hemodialysis, which accounts for roughly 69% of all kidney replacement treatment and 89% of all dialysis operations, is the most used kind of kidney replacement therapy globally.
Arteriovenous fistula (AVF) devices are produced to give dependable vascular access for dialysis treatments, and this has led to an increase in the prevalence of ESRD, which requires hemodialysis. The need for AVF devices has also been spurred by improvements in minimally invasive treatments including endovascular methods and embolization.
To increase their market domination, major firms in the arteriovenous fistula devices market are continually executing strategic initiatives, such as mergers, acquisitions, partnerships, and intense R&D work. Through these measures, the companies hope to improve their product lines, increase their market share, and promote advancements in AVF device technology.
Arteriovenous Fistula Devices Market Overview & Scope:
The arteriovenous fistula devices market is segmented by:
- Type: By type, the arteriovenous fistula devices market is segmented into AVF creation devices, AVF monitoring devices, and AVF maintenance devices. The AVF monitoring devices segment is expected to have a significant market share in this segment.
- Application: By application, the market is divided into hemodialysis, vascular access, and others. The stainless-steel segment is the fastest-growing segment.
- End User: By end user, the market is segmented into hospitals, ambulatory surgical centers. and others. The hospital segment in the end user is predicted to hold major share of the market during the projected period.
- Region: Region-wise, Asia Pacific is anticipated to account for a significant share of the arteriovenous fistula devices market particularly due to its increasing adoption of advanced dialysis techniques and safety-focused devices, and the rise in utilization of minimally invasive technologies is promoting the regional market.
Top Trends Shaping the Arteriovenous Fistula Devices Market:
- Rising Use of AVF Devices in Hospitals
Particularly in the context of hemodialysis treatments, hospitals are a key factor in the arteriovenous fistula devices market growth. Three hemodialysis treatments are typically covered by Medicare and the majority of other health insurance plans in the United States each week. Because of this coverage, hospitals can undertake a variety of AVF-required hemodialysis operations. A larger hospital requirement for AVF devices is brought about by the rising demand for hemodialysis treatments, which is supported by insurance coverage. As a consequence, the hospital sector is a significant factor in boosting arteriovenous fistula device market growth.
Arteriovenous Fistula Devices Market Growth Drivers vs. Challenges:
Drivers:
- Rising Prevalence of Chronic Kidney Disease: There is an increase in the prevalence of chronic kidney disease (CKD) is promoting market expansion as these conditions result in a rise in the number of patients requiring dialysis. According to the data from the Centers for Disease Control and Prevention (CDC) of 2023, over 1 in 7 US adults, which is approximately 35.5 million individuals are expected to have CKD while about 9 in 10 adults are not aware of having this disease and 1 in 3 adults having severe CKD are also not aware they have it in the country.
Moreover, as per the same source, the CKD is increasingly common in aged people with especially in those 65 years or older, which is about 65 percent, than in people who are between 45-64 years, with 12 percent, and 18 to 44, which is 6 percent. Additionally, according to the United Nations, by 2050, 1 in 6 people in the world, which is about 1.5 billion, will be over 65, an increase from 1 in 11 (703 million) in 2019.
Further, by the late 2070s, the global population aged 65 and older is expected to reach 2.2 billion. By the mid-2030s, there will be 265 million individuals aged 80 and older, outnumbering infants. This trend will contribute to increasing demand for arteriovenous fistula devices for the early detection and improvement in the survival rate of patients in the coming years.
- High Prevalence of End-Stage Renal Disease: The arteriovenous fistula devices industry is anticipated to expand due to a variety of factors, including the rising incidence of end-stage renal disease (ESRD) and the consequent increase in the number of patients needing haemodialysis. A total of 786,000 Americans is estimated to have end-stage renal disease (ESRD) or end-stage kidney disease (ESKD), according to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). In this group, 71% are on dialysis, while the remaining 29% have had kidney transplants.
- Growing Demand for Advanced Treatment Methods: The market for treating arteriovenous fistulas is anticipated to grow throughout the anticipated period as companies create innovative sclerotherapy techniques such as photodynamic therapy and antiangiogenic therapy. Players are motivated to create cutting-edge treatment technologies since the ideal therapy for a quick and complete recovery is still being developed. Additionally, increasing FDA approvals of noninvasive devices for creating arteriovenous fistulas have contributed to the arteriovenous fistula devices industry expansion throughout the anticipated period.
A self-generated arteriovenous fistula is also acknowledged to be the best access for hemodialysis transmission. On the other side, the surgical formation of an arteriovenous fistula is a sign of subpar technical performance, and many treatments are sometimes needed to promote maturation or maintain early patency.
- Increasing Utilization of AVF Creation Devices: The prevalence of ESRD is rising, and more people need dialysis therapy than ever before, which has increased the demand for AVF creation devices. By facilitating efficient vascular access, boosting patient care, and raising patient quality of life, AVF creation devices are essential in addressing the rising demand for dialysis therapy.
The arteriovenous fistula devices market is expanding as a result of the introduction of innovative products by key companies that speed up the AVF process. These ground-breaking approaches are meticulously crafted to streamline and optimize the production of AVFs, resulting in increased success rates and general development of the sector. For instance, the Ellipsys Vascular Access System from Medtronic can expand the number of professionals who perform vascular access treatments.
- Rise in Ongoing Investments and Innovations: The ongoing investments and innovation in medical treatments, especially for chronic kidney disease, followed by government-backed initiatives and policies to bolster medical access to dialysis, have created a surge in the demand for advanced filtration approaches, which has positively impacted the demand for arteriovenous fistula devices in the global market.
Likewise, the ongoing emphasis on home dialysis, followed by the development of excellence centers to bolster patient outcomes and increase their overall access to required infrastructure, is further acting as an additional driving factor. Additionally, major market players such as Medtronic and Becton Dickinson, which are investing in innovations and development to meet the current treatment requirements, have stimulated the overall market expansion in the coming years.
Challenges:
- Requirement of Skilled Healthcare Professionals: The AVFs devices utilizations demand fro specialized training and expertise and a shortage in skilled healthcare professionals can limit the procedure success rate and in turn market growth.
Arteriovenous Fistula Devices Market Regional Analysis:
- North America: Arteriovenous fistula devices are expected to see the fastest growth in North America. Kidney disease is a major health concern in North America, and AVF devices are essential for supplying hemodialysis patients with vascular access. The regional arteriovenous fistula devices market is expanding as a result of the increasing demand for AVF treatments and the focus on patient outcomes. The American Kidney Fund, Inc. claims that kidney illness is becoming more and more common, which is a worrying trend. These factors are the key reason propelling the arteriovenous fistula devices market in North America.
According to the Centers for Disease Control and Prevention, there are nearly 35.5 million Americans with kidney disease, of whom nearly 550,000 are on dialysis, and 815,000 are living with kidney failure. The same source also specified that the prevalence rate is much higher in people aged 65 years or older at 34%, followed by adults aged 45 to 64 years with 12%.
The kidney disease, nearly affecting 14% of American adults, has created an imbalance in the demand for new kidneys and the actual supply. As per the American Kidney Fund, in 2024, nearly 90,000 American patients were on the kidney transplant waiting list, with only 28,492 receiving new kidneys. This figure in 2023 stood at 27,332, showing 4.24% growth in receival.
Arteriovenous Fistula Devices Market Competitive Landscape:
The market is fragmented, with many notable players, including Medtronic, Polymedicure, Laminate Medical Technologies, Sonavex, Inc., BD, Venova Medical, Inc., Boston Scientific Corporation, and B. Braun SE, among others.
- Product in Pipeline: In April 2025, Venova Medical announced of Velocity pAVF System which is the product is a next-generation percutaneous AVF system developed to offer minimally invasive fistulas for haemodialysis, decreasing reinterventions and improving maturation in the patients.
Arteriovenous Fistula Devices Market Segmentation:
By Type
- AVF Creation Devices
- AVF Monitoring Devices
- AVF Maintenance Devices
By Application
- Hemodialysis
- Vascular Access
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
Table Of Contents
1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. Arteriovenous Fistula Devices Market BY type
5.1. Introduction
5.2. AVF Creation Devices
5.3. AVF Monitoring Devices
5.4. AVF Maintenance Devices
6. Arteriovenous Fistula Devices Market BY Application
6.1. Introduction
6.2. Hemodialysis
6.3. Vascular Access
6.4. Others
7. Arteriovenous Fistula Devices Market BY end user
7.1. Introduction
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Others
8. Arteriovenous Fistula Devices Market BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. United Kingdom
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. United Kingdom
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Others
8.5. Middle East & Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Israel
8.5.4. Others
8.6. Asia Pacific
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.2. Polymedicure
10.3. Laminate Medical Technologies
10.4. Sonavex, Inc.
10.5. BD
10.6. Venova Medical, Inc.
10.7. Boston Scientific Corporation
10.8. B. Braun SE
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
Companies Profiled
Polymedicure
Laminate Medical Technologies
Sonavex, Inc.
BD
Venova Medical, Inc.
Boston Scientific Corporation
B. Braun SE
Related Reports
| Report Name | Published Month | Download Sample |
|---|---|---|
| Ligation Devices Market Size & Share: Industry Report, 2023-2028 | January 2024 | |
| Insulin Storage Devices Market Insights: Share, Forecast 2030 | July 2025 | |
| Assisted Walking Devices Market Size: Industry Report, 2024-2029 | May 2024 | |
| Bathroom And Toilet Assist Devices Market Report: Forecast 2030 | August 2025 | |
| Deep Brain Stimulation Devices Market Report: Size, Forecast 2030 | January 2025 |